Norbrook Laboratories has launched Norfenicol Solution for Injection (florfenicol), a broad spectrum antibiotic licensed for the treatment of pneumonia in cattle and pigs.
Dr Barry McInerney, Norbrook's GB Veterinary Advisor said: "With many farmers preparing for winter housing, the launch of Norfenicol is timely as pneumonia represents the most common disease of housed cattle in the UK costing the agricultural industry an estimated £80m per year. Norfenicol is an easy to inject, cost effective treatment of pneumonia which kills bacteria quickly, and is available in a durable plastic bottle. Studies have shown florfenicol, the active ingredient in Norfenicol, to have a high bacteriological and clinical efficacy (100% and 96% respectively) against susceptible bacteria in the treatment of calf respiratory tract diseases."
Norfenicol is indicated for the treatment of bacterial respiratory disease in cattle associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somniand for the treatment of acute outbreaks of respiratory disease caused by strains of Actinobacillus pleuropneumoniae, and Pasteurella multocida in swine.
Dr McInerney added: "NSAIDs have also been shown to be a beneficial ancillary therapy in treating bacterial pneumonia, to alleviate pain as well as to reduce inflammation and pyrexia. Norbrook has a range of NSAID products which are available as an adjunctive treatment for pneumonia in cattle, including Loxicom 20 mg/ml solution for injection for cattle, pigs and horses."
For further product information, visit www.norbrook.com
This is the first confirmed finding of the virus in the UK this winter and tests have shown it is closely related to the H5N6 strain that has been circulating in wild birds across Europe in recent months. This is different to the strains which affected people in China last year and Public Health England have advised the risk to public health is very low. The Food Standards Agency have said that bird flu does not pose a food safety risk for UK consumers.
UK Chief Veterinary Officer, Nigel Gibbens, said: "This is the first time avian flu has been identified in the UK this winter and while the disease does not represent a threat to the public, it is highly infectious and deadly to birds.
"As the virus has been circulating across Europe, this finding has not come as a surprise. But it is vital that anyone who keeps birds - whether a few in a back garden or thousands on a farm - is vigilant for any signs of disease, reports suspect disease to APHA and maintains good biosecurity to reduce the risk of their birds becoming infected."
Local measures will be put in place to manage the potential threat. These include a local Avian Influenza Prevention Zone (AIPZ) in Dorset as a precautionary measure to prevent disease spread to other birds. This means all captive bird keepers in the area will have to implement enhanced biosecurity measures such as feeding and watering birds undercover so that wild birds do not co-mingle with kept birds; minimising movement in and out of bird enclosures; cleaning and disinfecting footwear; and keeping areas where birds live clean and tidy.
There are no plans for culling or movement restrictions.
BVA President John Fishwick said: "I’d encourage vets to reassure their clients that this strain of Avian Influenza poses a very low risk to public health and the food chain. Defra have acted swiftly to try and contain further spread of the disease, which has likely come from migratory birds, yet vets and poultry owners should remain vigilant for signs of the disease."
British Veterinary Poultry Association (BVPA) President Phil Hammond added: "It’s really important that all bird keepers heed biosecurity advice issued by Defra, and maintain the highest biosecurity standards. Any suspicion of Avian Influenza should be reported to the APHA as soon as possible."
Up-to-date advice and guidance on Avian Influenza is available on the Gov.UK website, including how to spot it, what to do if you suspect it, and measures to prevent it: https://www.gov.uk/guidance/avian-influenza-bird-flu#about-avian-influenza
For further advice on Avian Influenza contact the Defra Helpline on 03459 33 55 77.
Trade should not be affected following the findings in wild birds, according to the rules of the World Animal Health Organisation (OIE).
Photo: Wild Birds, Shutterstock / aDam Wildlife
Elanco Animal Health has highlighted the results of a new study1 which concludes that Duvaxyn IE-T Plus stimulates a highter protective antibody response than four other equine influenza vaccines commercially available in Ireland.
The trial compared the antibody responses of unvaccinated Thoroughbred weanlings following primary vaccination with Duvaxyn IE-T Plus, Equilis Resequin, Equip FT, Equilis Prequenza Te and ProteqFlu Te.
In addition, following the first vaccination, 43% of the weanlings failed to seroconvert. However, amongst those vaccinated with Duvaxyn IE-T Plus a 100% response rate was observed. The failure rate amongst vaccines other than Duvaxyn IE-T Plus ranged between 7.7% and 78.6%. By the time of the third vaccination (31 weeks after the first) all horses had responded to vaccination.
The study, conducted by the Irish Equine Centre in Johnstone, the Department of Life Sciences at the University of Limerick and the Department of Statistics at Trinity College in Dublin, involved 66 unvaccinated Thoroughbred weanlings on four different stud farms. Following primary vaccination (V1, V2 and V3) with the five vaccines antibody responses were monitored for six months post V3 by single radial haemolysis. Elanco says that the correlation between SRH antibody levels and protection has been well-established and accepted2.
Elanco also highlights a recent study3 which it says demonstrated the ability of Duvaxyn IE-T Plus equine influenza vaccine to cross protect against A/equi-2/Richmond/1/07 (H3N8) two weeks after a two dose primary course. The company says that this is believed to be the first demonstration of cross protection by a current UK equine influenza vaccine against a Florida sub-lineage clade 2 reference strain.
Anna Jackson, national veterinary manager for Elanco Companion Animal Health said: "Most studies carried out by vaccine companies take place under controlled conditions that are optimal for effective vaccination. This latest study shows how well Duvaxyn IET plus stimulates immunity under field conditions against both vaccinal and non-vaccinal strains. Importantly, all the weanlings vaccinated with Duvaxyn seroconverted after the first vaccination, conferring earliest and most reliable protection for these vulnerable animals."
For further information please contact your local Elanco Companion Animal Health key account manager or phone 01256 779881.
References:
Henry, who works at Crowshall Veterinary Services in Norfolk, graduated from the Royal Veterinary College in 2018.
He is the lead products export vet for Crowshall and was instrumental in the business’s preparation for Brexit.
He is also one of the founding ‘green champions’ at the practice, which has become the first specialist poultry practice to be accredited with Investors in the Environment.
The panel of seven judges from said that within just three years Henry has gained much experience, showing evidence that he has contributed to reduced antibiotic usage as well as improved biosecurity and improved bird welfare, health and production for his clients.
They said: “He has clearly shown he has worked with colleagues as a team, and has introduced new initiatives in his practice including improving mental health of staff and assisting in sustainability.”
James Porritt, National Pig and Poultry Sales Manager of award sponsors Zoetis, said all three finalists were very strong candidates: “It was great to see the work they have all done recognised at the awards.
"It was fantastic to see Henry win and hope the award spurs him on to continue his bright future in the poultry industry.”
Photo: Henry Lamb holding the Young Farm Vet trophy, alongside Jonathan Agnew (left) and James Porritt of the award sponsors Zoetis
Some 150 practices currently use Vidivet, which was set up by Ben Sweeney MRCVS (pictured) in 2020.
He said: “I started VidiVet as I wanted people to be able to access high quality, impartial care for their pets that allows them to make more informed decisions around their treatment with expert information, rather than resorting to the internet.
"As a vet I also wanted to make life easier for those working within veterinary practices.
"VidiVet relieves part of the burden veterinary practices face by offering a trusted digital triage service for their clients.
"Our digital service can provide a helpful extension to a practice which dramatically reduces admin and saves time for the in-house team.
"Crucially, we offer peace of mind and reduce anxiety for pet owners, and with over 96% of VidiVet out of hours calls redirected to the pet owner’s registered vet, it can really enhance the practice bond by using digital care to augment physical care."
Before the Provet partnership, OOH case notes were sent to client practices which then had to enter them onto their systems manually.
Vidivet says the intregration with Provet means less admin and time savings for practices and a quicker follow up for pet owners.
https://vidivet.com
https://www.provet.cloud
The RCVS Disciplinary Committee has refused an application for restoration to the Register by Mr Joseph Holmes, who was struck off in 2011 for serious professional misconduct associated with surgery he had carried out on a dog and two cats.
At a two-week Disciplinary Committee hearing that concluded on 14 January 2011, two separate complaints had been considered against Mr Holmes, formerly of Waltham Veterinary Clinic, Grimsby. These involved a total of 31 charges, of which 28 were found to amount to serious professional misconduct. Mr Holmes was found to have advised on and undertaken surgical procedures without sufficient clinical grounds or consideration of alternative treatment options; failed to obtain the informed consent of his clients; undertaken procedures outside his area of competence; failed to refer or discuss the option of referral to a specialist; and, failed to provide his patients with adequate pain relief.
The then-Committee directed Mr Holmes' name be removed from the Register, whereupon he appealed to the Privy Council, who dismissed his appeal on 22 December 2011, concluding that removal from the Register "was the only disposal which could properly reflect the primary need to serve both the interests of animal welfare and the reputation of the veterinary profession".
At the hearing last week the Committee considered several factors in relation to Mr Holmes' application for restoration. Although Mr Holmes gave assurances that he accepted the findings of the original hearing, this contrasted completely to the robust way in which he had challenged all of these at that hearing and the majority in his appeal. Mr Holmes had been off the Register for only 12 months - just over the minimum period before an application for restoral was permitted. The Committee took the view that the application was premature and was not satisfied that Mr Holmes truly appreciated the seriousness of the findings made against him.
In response to questions from the Committee, Mr Holmes showed deficiencies in his knowledge, such as not knowing all of the constituents of the human drug, Anadin Extra, in spite of having produced a record of continuing professional development (CPD) on analgesia and having prescribed it to a dog in the original complaint. He did not provide records of CPD for 2010, 2011 and 2012, and although recognising that working in isolation from the majority of his fellow practitioners had contributed to his failures, he had made very limited efforts to observe first-opinion veterinary practice.
The Committee accepted at face value Mr Holmes' statement that he had not worked as a veterinary surgeon whilst de-registered, and accepted that removal from the Register had had a profound effect on Mr Holmes and his family, including the sale of his practice. It noted that Mr Holmes produced only the testimonials previously submitted to the Privy Council, which were of limited scope.
Professor Peter Lees, chairing and speaking on behalf of the Committee said: "Having regard to all the factors set out above, the Committee regrets that it is not satisfied that the applicant is fit to be restored to the Register. Accordingly, the application is refused."
New research led by academics at the University of Bristol's School of Veterinary Sciences has shown that 85% of pet cats are not neutered by the recommended age of four months, possibly due to cat owners needing better information about when to neuter their cat.
In 2006, the recommended neutering age of pet cats reduced from six to four months of age. The study assessed the proportion of cats neutered at these ages. Data was obtained from owner-completed questionnaires at recruitment, when kittens were aged eight to 16-weeks, and six and a half to seven months of age. Demographic and lifestyle factors were also assessed for potential association with neuter status.
The researchers found that of the 751 cats in the study, 14.1% and 73.5% had been neutered at or before four and six months of age, respectively. Cats were significantly more likely to be neutered at four months if their owners had always intended to have their cat neutered by this age. They were also significantly more likely to be neutered at four months if they were microchipped or from households in deprived regions.
The likelihood of being neutered, compared with unneutered, at six months of age was significantly increased for cats that were insured, obtained from an animal welfare organisation, given their second vaccination, from a household with an annual income of over £10,000 and owned by people intending to have their cat neutered by this age.
Dr Jane Murray, Cats Protection Research Fellow in Feline Epidemiology, said: "Neutering is recommended as an effective way of reducing the number of unwanted cats in the UK. Our study found that age of neutering was associated with the age of intended neutering. Cats can reach puberty at four to five months of age therefore, it is important that owners are aware of the recommended age of neutering at four months, to reduce the number of unplanned pregnancies that occur."
The study suggests that while neutering rates were high at six months of age, they were low at four months of age, and that further work is required to publicise the recommended neutering age of four months to cat owners.
Paper: The neuter status of cats at four and six months of age is strongly associated with the owners' intended age of neutering, C. P. Welsh, T. J. Gruffydd-Jones and J. K. Murray, Veterinary Record published online April 19, 2013.
Zoetis says Lokivetmab targets and neutralizes canine interleukin-31 (IL-31), a cytokine associated with atopic dermatitis which sends the itch signal to the brain.
The company has submitted an application for marketing authorisation of the product, which is conditionally licensed in the US and Canada under the name Canine Atopic Dermatitis Immunotherapeutic, in the European Union.
The new data was presented at the 8th World Congress of Veterinary Dermatology (WCVD).
Supporting the efficacy of Lokivetmab in canine AD, Zoetis presented the results of a randomized, double-blind, placebo-controlled dose determination trial to evaluate efficacy of three doses of lokivetmab (0.125, 0.5 or 2.0 mg/kg) in providing relief from the clinical signs of pruritus (itching) and other clinical signs associated with atopic dermatitis in dogs.
Veterinary investigators at 15 clinics enrolled 245 client-owned, live-at-home dogs with chronic atopic dermatitis. Lokivetmab or a placebo was administered by subcutaneous injection on day 0, and efficacy was evaluated periodically over 56 days. Dog owners assessed their dog’s pruritus using a visual analog scale (VAS), and investigators assessed the associated skin lesions using Canine Atopic Dermatitis Extent and Severity Index-03 (CADESI-03) scores.
Lokivetmab, injected once subcutaneously, provided dose-dependent improvement in owner-assessed pruritus and clinician-assessed CADESI-03 scores for four to six weeks in dogs with atopic dermatitis.
Zoetis also presented results of a randomized, double-blind, placebo-controlled trial to assess the safety of lokivetmab at the nominal dose tested of 1 mg/kg (range, 1-3.3 mg/kg) in the treatment of canine atopic dermatitis. Veterinary surgeons evaluated 245 client-owned, live-at-home dogs with chronic, naturally-occurring atopic dermatitis. These dogs were randomized at a 2:1 ratio to receive two monthly injections of lokivetmab (162 dogs) or placebo on days 0 and 28.
No immediate hypersensitivity reactions were observed and there were no clinically important differences in clinical pathology results. No apparent adverse drug interactions were reported. Dogs studied were taking a wide variety of medications, which is important because multimodal therapy is commonly prescribed for dogs with atopic dermatitis. Adverse events were reported at a similar frequency between the groups.
Chris, who is moving from Willows, will develop both the medical cardiology service and deliver a new interventional cardiology service to complement the existing surgical offering at Paragon, which is investing around £145,000 in ultrasound equipment and operating facilities to support the service.
Chris said: “I’ve had a great time at Willows and couldn’t think of a better place than Paragon to continue my passion for all things cardiology.
“It’s an exciting time to be joining Paragon, which is growing phenomenally to service the region whilst it cements itself as one of the leading referral centres in the north of England.
“The investment and expansion which is taking place at Paragon will allow us to develop another globally-recognised cardiology centre within Linnaeus.”
For more information, visit: www.paragonreferrals.co.uk
The Forestry Commission, together with other agencies and landowners, is stepping up efforts to find out why some dogs have fallen ill while on countryside walks.
Over 50 cases of so called Seasonal Canine Illness (SCI) occurred during the autumn of 2009 and 2010 in Nottinghamshire, Lincolnshire, East Anglia and Warwickshire, although there have been reports from further afield.
Symptoms include severe vomiting, diarrhoea, shaking / trembling and high temperature, and have generally been displayed by animals within 24 hours of walking in the countryside, especially in woodlands. A small number of dogs have died. The cause of Seasonal Canine Illness remains unknown.
Jo Atkinson, from the Forestry Commission, said: "Although no cases have yet been reported this year, we are working with our many partners to get a clearer picture of the distribution and reasons behind this upsetting sickness. Both dog owners and vets can play their part too in helping protect cherished pets."
Moves to tackle the illness include:
Veterinary surgeons are asked to:
The report, which was developed in consultation with BVA members, devolved branches, BVA specialist divisions and other stakeholders, outlines the essential role that the UK veterinary workforce plays in not only caring for animals, but in enabling trade, ensuring food hygiene and safety, and undertaking cutting-edge research.
Non-British EU veterinary surgeons are critical to the UK veterinary workforce. Around 50% of veterinary surgeons registering to practise in the UK each year come from overseas, with the vast majority of these coming from the rest of the EU. Yet one-fifth of vets are already reporting that it has become harder to recruit since the EU Referendum.
To secure the best possible outcomes for animal health and welfare, public health, and the veterinary profession, Brexit and the veterinary profession sets out 52 recommendations for the short, medium and long term, including calling on the next Government to:
BVA President Gudrun Ravetz said: "Vets provide the foundation for the UK’s work on animal health and welfare. Veterinary teams up and down the country support the UK’s 11 million pet-owning households; not a penny of the UK’s £13 billion agri-food industry could be realised without vets; and we are an integral part of the international scientific community, annually bringing in over £50 million for research and development projects.
"The veterinary profession is in a unique position from which to offer the next Government evidence-based policy recommendations to ensure animal health and welfare, public health and other standards are at the very least maintained as we exit the EU.
"We believe Brexit also presents us with opportunities, for example, to develop a strong, competitive food industry with full consumer confidence at home and abroad as well as to position the UK as a world leader in high animal welfare - and a strong veterinary workforce is vital in achieving this."
Brexit and the veterinary profession was developed and written by the BVA Brexit Working Group, under the chairmanship of Alick Simmons, former UK deputy Chief Veterinary Officer, and was agreed by BVA Council in April.
The report builds on BVA’s Brexit Principles, agreed by Council in September 2016, and covers seven areas of public policy: veterinary workforce, animal health, animal welfare, food hygiene and safety, veterinary medicines, research and development, and trade.
Two further sections of the report consider issues relating to devolution and to Northern Ireland’s unique position as the only part of the UK to share a land border with an EU member state.
With a snap General Election due in five weeks’ time, BVA has produced a 20-point manifesto of key recommendations covering both Brexit and wider policy issues, which has been sent to the main political parties’ manifesto-writing teams and to BVA’s Honorary Associates.
Brexit and the veterinary profession and the manifesto for the 2017 General Election are available at: www.bva.co.uk/brexit.
The modules, which are presented by US veterinary oncology specialists Dr Chad Johannes and Dr Sue Ettinger, are titled: ‘Mastering Mast Cell Tumours’, ‘Treating Canine Mast Cell Tumours’ and ‘Stelfonta’.
Each of the modules offer 30 minutes of bitesize, interactive CPD and are suitable for both veterinary surgeons and nurses.
Dr Neil Mottram MRCVS, Technical Product Manager at Virbac said: ‘We appreciate that for the majority of veterinary teams, finding time for CPD is pretty challenging at present. We therefore hope that the bitesize, on-demand format of these modules can provide the perfect solution, whilst still delivering high quality CPD’.
The modules can be accessed at: vet-uk.virbac.com/stelfonta/education
Virtual lunch and learn meetings are also available from Virbac Territory Managers.
For more information, speak to your Virbac Territory Manager, or visit vet-uk.virbac.com/stelfonta
Dechra Veterinary Products has launched Osphos, an intramuscular clodronic acid injection for the control of clinical signs associated with the bone resorptive processes of navicular syndrome in horses, the only such licensed product in the UK.
Dechra says it expects Osphos to change the way chronic lameness caused by navicular syndrome is tackled by equine vets.
According to the company, clinical trials of Osphos showed 74.7% of horses experienced improvement by at least one lameness grade at 56 days post treatment.
Dechra brand manager Emma Jennings said: "Osphos intramuscular injection contains the bisphosphonate clodronic acid which inhibits resorption in the navicular bone by binding to hydroxyapatite crystals and by direct cellular effects on osteoclasts.
"We are delighted with the results of the trials, which proved that Osphos is effective at 6 months post-treatment. We're looking forward to being able to support equine vets, vet nurses and practices by providing an intramuscular Clodronic acid injection for horses."
Dechra also says studies showed that mild transient colic was seen following just 1.6 per cent of treatments.
Osphos 60 mg/ml solution for injection for horses is available from September 2014.
Dechra says the ability to split Prednicortone into 1.25 mg doses is particularly useful when used alongside Zycortal, the only licensed treatment for canine Addison’s disease in Europe.
Dechra Brand Manager Carol Morgan said: "Dogs with primary Addison’s disease have insufficient levels of natural mineralocorticoids (primarily aldosterone) and glucocorticoids (primarily cortisol). Zycortal contains DOCP, a synthetically produced steroid hormone, which acts in a similar way to aldosterone.
"It causes sodium retention and potassium excretion, helping to maintain water balance but Zycortal only replaces the mineralocorticoid. Therefore, a daily oral glucocorticoid treatment, such as Prednicortone, is needed to address the cortisol deficiency, alongside Zycortal.
"The amount of glucocorticoid administered should be adjusted to the individual dog’s need and it is likely that the dose required will be reduced over time."
She added that a combined approach of Zycortal and Prednicortone allowed independent dose titration of both mineralocorticoids and glucocorticoids.
"The advantage of prescribing the two treatments is that the dosage for each component can be tailored to an individual animal’s response. This leads to a reduction in the side effects usually associated with over-supplementation of glucocorticoids."
There are 250 tablets in a pack and Prednicortone offers accurate dosing using a double divisible SmartTab format and accurate dispensing via blister packs. The flavoured tablets also encourage easy oral administration.
For more information, visit www.dechra.co.uk.
Pets at Home has announced the acquisition of the joint venture practice business, Vets4Pets, adding 93 stand-alone veterinary practices to the 116 in-store practices it already operates under the Companion Care brand.
Providing veterinary and grooming services to consumers is seen as the way for the retailer to overcome competition from the Internet.
Nick Wood, CEO of Pets at Home said: "The expansion of our veterinary business is a key element of our growth strategy for Pets at Home, providing additional services to our customers within our stores or close to our customers' homes. The acquisition of Vets4Pets is an important step in the delivery of this strategy. Vets4Pets is highly complementary to Companion Care, sharing fundamental beliefs and values, and is an excellent strategic fit for Pets at Home. I am delighted that Peter Watson has agreed to stay with the business. His knowledge and experience will be invaluable as we continue to build our veterinary business with both stand-alone and in-store practices. He will work closely with Jane Balmain, the Managing Director of our Companion Care business as we integrate the two businesses."
Peter Watson, Founder and CEO of Vets4Pets said: "Pets at Home holds a unique place in the retail landscape, built on a strong identity and a real passion for people and pets. It is clear to me that Nick and his team have a similar vision for their veterinary business. I'm delighted to be working with Nick to continue to expand the veterinary business by offering attractive joint venture opportunities for vets in stand alone locations to complement the offering in Pets at Home stores."
Companion Care MD, Jane Balmain added: "Companion Care and Vets4Pets each enjoy a strong reputation among both vets and customers. Both businesses have a common business model, offering joint venture partnerships with vets. I am looking forward to working alongside Peter as we bring the businesses together, continue to expand our joint venture partnerships and accelerate our growth."
Vets4Pets' UK operational centre will remain in the East Midlands, with its support functions being split between Companion Care's operation in Oxfordshire and Vets4Pets' Guernsey office.
The RCVS's new Royal Charter has come into effect today, meaning that the whole of the veterinary nursing profession in the UK is now regulated.
The new Charter received the Great Seal of the Realm and was collected from the House of Lords by RCVS Registrar Gordon Hockey and Policy Consultant Jeff Gill (pictured right). It had previously been approved at a meeting of the Privy Council on 5 November 2014.
Under the changes instituted in the new Charter, there are no longer listed veterinary nurses and all those formerly on the List have effectively been moved to the Register and become RVNs.
As a result they will now be expected to undertake the minimum requirement for continuing professional development (CPD) of 45 hours over a three-year period, will need to follow the RCVS Code of Professional Conduct for Veterinary Nurses,and will be subject to the College’s disciplinary system in cases of serious professional misconduct. Any veterinary nurse removed or suspended from the Register will not be entitled to give medical treatment or carry out minor surgery.
Gordon said: “This is a proud day for us and an important day for the profession as a whole. We worked very hard to get to this point and I would like to thank all those who helped us along the way including RCVS and VN Council members, College staff and the members of the profession and representative organisations, in particular the BVA and BVNA, that responded to our consultation on the proposed Charter last year.
“This Charter clarifies the role of the College and its aims and objectives while also modernising many of our regulatory functions. This represents another significant step towards the College becoming a first rate regulator.
“Critically, this Charter fulfils one of our long-term ambitions to create a coherent regulatory system for veterinary nurses and to recognise them as true professionals, dedicated to their vocation, their development and proper conduct.”
During this year’s renewal period for veterinary nurses (in the autumn), those formerly on the List will be expected to confirm that they are undertaking CPD and will also need to disclose any criminal convictions, cautions or adverse findings when they renew their registration. The annual renewal fee for veterinary nurses remains unchanged.
A detailed set of frequently asked questions for former listed veterinary nurses can be found at www.rcvs.org.uk/rvn.
The relevant section of the Government advice states: "This [key worker status] includes those involved in food production, processing, distribution, sale and delivery, as well as those essential to the provision of other key goods (for example hygienic and veterinary medicines)."
The RCVS/BVA statement, which is intended to help veterinary surgeons decide whether or not they can claim ‘key worker’ status and ask for their children to continue to be taken into schools, reminds veterinary surgeons to consider the wider societal picture and ensure that they only claim ‘key worker’ status if absolutely necessary.
The statement also stresses that the RCVS Code of Professional Conduct responsibility of the veterinary surgeon to take steps to provide 24-hour emergency first aid and pain relief to animals according to their skills and the specific situation continues, and veterinary practices will need to continue to carry out this work. It is important that animal owners are able to focus on their own health, and not need to worry about their pets. Both the RCVS and BVA believe that veterinary surgeons who are providing this essential work can be considered key workers.
The statement in full is as follows:
Veterinary surgeons as key workers in relation to school closures
RCVS and BVA appreciate that veterinary surgeons will feel a great deal of uncertainty at the present time, and that many will be facing considerable difficulties due to the closure of schools for most pupils.
The official government advice can be found here: https://www.gov.uk/government/publications/coronavirus-covid-19-maintaining-educational-provision/guidance-for-schools-colleges-and-local-authorities-on-maintaining-educational-provision.
The guidance emphasises that if children can be at home then they should be, in order to help to prevent the virus from spreading.
The government has granted key worker status by sector rather than profession. Some veterinary work will definitely fall into the ‘key worker’ category. RCVS and BVA are therefore providing some additional advice below, following consultation with the UK Chief Veterinary Officer:
SummaryAt this time the provision of public health and the maintenance of food production need to take priority, and veterinary surgeons working in these areas should be considered key workers.
Veterinary surgeons working in emergency care can also be considered key workers. This will not apply to every veterinary surgeon in clinical practice, and practices may need to consider rationalising their services to achieve this.
The guidance has been welcomed by both the BSAVA and BEVA. David Mountford, Chief Executive of BEVA said: "As veterinary professionals we are duty-bound to provide essential care, relieve suffering and protect the health of the public. Recognition as key workers in such circumstances is welcomed but we would encourage vets to only add to the burden faced by schools where animal welfare is at risk and all other avenues have been explored."
The study “Hypoadrenocorticism in dogs under UK primary veterinary care: frequency, clinical approaches and risk factors1”, identified dogs diagnosed with hypoadrenocorticism from the electronic patient records of practices participating in the UK VetCompass programme during 2016.
The study aimed to estimate the frequency of hypoadrenocorticism in dogs under primary veterinary care in the UK, describe the diagnosis and clinical management of hypoadrenocorticism and report the risk factors for the disease.
Cases were categorised as having a laboratory-confirmed or presumed diagnosis, based on the information available in the electronic patient records. Multivariable logistic regression was used to identify demographic risk factors.
A total of 177 hypoadrenocorticism cases were identified from 905,543 dogs in 2016; 72 laboratory-confirmed and 105 presumed. The one-year period prevalence for hypoadrenocorticism in all dogs was 0.06%.
The most commonly recorded clinical signs included:
Imogen Schofield, corresponding author for the paper, said: “By presenting epidemiological data on dogs with hypoadrenocorticism attending primary-care practice, this study provides representative and relatable information for vets working in primary-care practice in the UK. It should be borne in mind that diagnostic and clinical management data were reported for laboratory-confirmed cases only.
“Breed, age, neuter status and insurance status were all associated with a laboratory-confirmed diagnosis of hypoadrenocorticism. The standard poodle had 51.38 times the odds of hypoadrenocorticism compared with crossbreeds. The labradoodle (OR: 7.40) and West Highland white terrier (OR: 5.84) also had increased odds.
Nicola Di Girolamo, Editor of JSAP, said: “This is the largest study to date to provide benchmark data on hypoadrenocorticism in dogs under primary veterinary care in the UK. Given that the frequency of hypoadrenocorticism has rarely been reported, it is typically difficult to diagnose due to the non-specific clinical signs associated with the disease, and many previous studies have focussed on referral populations. This is a welcome publication adding to the evidence base of an important topic.”
The full article can be found in the May issue of the Journal of Small Animal Practice and can be read online here: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13285. It is open access and can be freely accessed by anyone.
Reference
whatstherisk.co.uk has been created for all practice staff and contains advice from parasitologists Ian Wright and Eric Morgan.
Topics include advice on practical risk assessments, how risk-based prescribing can work with health plans as well as how to get owners involved to make risk assessment and personalised prescribing quicker and simpler.
Boehringer says that all the materials and advice have been developed in line with RCVS Practice Standards and the BVA's guidance on the responsible use of parasiticides.1,2
Sharron Woods, NexGard brands Franchise Manager said: “With knowledge about parasitic risk low among dog owners, alongside increasing scrutiny on the potential overuse of parasiticides, we’re delighted to be at the forefront of supporting vets, pet owners and the wider industry in driving best-practice risk assessment and responsible parasite control."
References
Dechra Veterinary Products has launched an online CPD programme to help the veterinary profession diagnose, manage and treat dogs suffering from Hyperadrenocorticism (Cushing's syndrome).
The new Canine Hyperadrenocorticism CPD module has been designed to help vets by providing them with a comprehensive overview of the condition, which they can study in their own time and at their own pace. According to Dechra, it aims to take the guesswork out of managing this complex condition and to support vets in improving the quality of life of Cushing's syndrome patients.
It is the latest online CPD course to be offered through The Dechra Academy, a resource which offers a range of learning and support content and client materials. Accounting for six hours' CPD, the Cushing's syndrome online module complements a CPD road show on the disease recently completed by Dechra around the UK. Over 350 vets attended the sessions and further meetings are scheduled for later in 2011.
Greg Williams, Veterinary Technical Services Manager, said: "Cushing's syndrome remains a challenge to the profession because the clinical signs can easily be confused with those of other disorders and tests results are not always clear cut. We know from the strong attendance at our road show earlier this year that there is a real hunger in the profession to build stronger understanding of the disease.
"Through The Dechra Academy, we bring together the latest thinking on a range of clinical conditions and provide practical, up to the minute training, tips, tools and case studies to help vets spread best practice across their clinical and nursing staff. We also offer CPD in a range of formats - face to face, online and video - to ensure we can accommodate the needs of even the busiest practice.
"We're delighted to launch this new module on Cushing's syndrome and know that it will prove to be a useful tool for vets in practice."
For further information on The Dechra Academy or Cushing's syndrome CPD, please contact your Territory Manager, ring Dechra on 01939 211200 or visit www.dechra.co.uk/academy.
Dechra Veterinary Products Ltd is part of Dechra Pharmaceuticals PLC ('Dechra') and offers a range of pharmaceutical products and instruments to veterinary practices in the UK. The company specialises in the development and marketing of licensed branded pharmaceuticals and specialist premium pet foods for companion animals in the global veterinary market. Dechra is committed to developing new products and services that support the work of veterinary professionals and enhance the lives of their patients and also to investing in products and added-value services that deliver its promise to support veterinary professionals and pet owners.
The company is now inviting practices to sign up for the free Beta trial and shape the development of the new platform and how video consultations can be integrated into traditional ways of working.
The platform, which can be branded with the practice logo, uses an app which clients download onto their mobile devices and use to book appointments. The system has its own appointment booking system, but also integrates with Vetstoria. When an appointment is booked via video, practitioners see it in their PMS. They then visit their online account, select the relevant appointment and click ‘start video call’. Payment can be collected from the owner prior to the consultation.
Susie Samuel, Managing Director of VetHelpDirect said: "While developing this product, we have been mindful that the use of telemedicine in our industry has been hugely controversial. We believe that inviting local vets to trial and refine this technology, using their team to work with their own clients removes many of the risks and dangers otherwise inherent in the proposition."
I agree wholeheartedly. The controversy over telemedicine has been about the idea of allowing the prescription of drugs to animals that have not been seen in person. Using a service like this (or the one launched by the Virtual Vet Group last year) to offer video consultations to patients that are already under your care strikes me as an altogether different kettle of fish. I think it will help improve engagement with existing clients, by reducing unnecessary trips to the practice for follow-up or post-operative consultations, saving time, money and the planet.
Susie added: "In our fast-moving world pet owners are increasingly reliant on technology and expect to be able to access services easily. The results of our recent VetHelpDirect research of 419 owners showed 38% of survey respondents said they would like to have the option of a video consultation if it was offered by their own vet. If we are to keep up with this demand, we need to embrace new ways of working."
VetHelpDirect says that whilst it believes that the growth in the use of this technology will change the way veterinary medicine is practiced, video consultations will always work alongside in-person consultations, as just one tool in an overall strategy of care, and certainly will not replace face to face diagnosis.
Let's hope so.
Susie added: "What is clear from our research is that whilst clients would like to be able to have video consultations with a vet their strong preference is for this to be with their own vet; whilst 38% of people would use video consultations with their own vet this falls to only 7% if it is provided by a vet not known to them.
"Of course, telemedicine is by no means the answer in every case, what the new service does offer is flexibility for practitioners and the ability to work in new ways that will benefit the animals and owners. For example, giving free telephone advice has become common place in many practices but is very hard to monetise. Video consultations provide a commercial solution to this problem.”
For more information, or to join the trial, contact Susie Samuel susie@vethelpdirect.com
Anna, who has been with the Hertfordshire-based referral centre for seven years, is now an RCVS, EBVS and American Specialist in Small Animal Internal Medicine.
She graduated from The University of Liverpool in 2007 and spent four years working in general practice in Kent.
She then went on to complete a rotating internship, followed by a residency in Small Animal Internal Medicine at the Royal Veterinary College where she gained her Master’s degree and Diploma.
Whilst enjoying all aspects of Internal Medicine, she has special interests in endocrinology and haematology. The latter, combined with her love for cats, has fuelled her interest in feline transfusion medicine.
Anna said: “I am delighted to have been appointed as Head of Internal Medicine at Davies.
“The Internal Medicine team are the detectives who work to establish a diagnosis, and we often have the added bonus of working closely with other disciplines in our multi-disciplinary environment.
"It is a challenging and highly rewarding service, with a wide variety of cases and I am delighted to work with a first-class team of clinicians and nurses.”
The Bella Moss Foundation (BMF) has announced the launch of a mobile app version of its online veterinary practice hygiene audit.
The app, which was developed with the help of Ceva Animal Health, is now available to download free from Google Play (for Android-based smartphones) and itunes.
To download the audit app for iOS visit: https://itunes.apple.com/gb/app/bella-moss-foundation-practice/id1096044355
To download the audit app for Android visit: https://play.google.com/store/apps/details?id=thebellamossfoundation.bmfhygieneself_auditapp
The original online check list, which continues to be hosted on the BMF website, was devised by BMF's team of clinical advisers, including VN Louise O'Dwyer and vets Pam Mosedale, Tim Nuttall and Chris Laurence. It enables staff to rate hygiene protocols across every area of their practice, resulting in a room-by-room percentage hygiene score, as well as an overall contamination risk score.
Since its launch last year, more than 150 practices have used the web-based tool and BMF hopes many more practices will download the app and use it regularly to check and maintain their hygiene standards.
BMF founder and infection control campaigner Jill Moss said: "We are absolutely thrilled to have teamed up with Ceva to create this new super-accessible app version of our audit tool. We've been really pleased to see uptake of the Practice Hygiene Self-Audit online, and hope more practice staff give the smartphone app a go.
"While we all know how important infection control is, sometimes it's the basics that get forgotten in a busy practice environment – but now, with our free audit app in your pocket, implementing good hygiene processes could not be easier, so there's no excuse!"
For more information about BMF, visit www.thebellamossfoundation.com or visit http://www.thebellamossfoundation.com/practice-hygiene-self-audit/ to complete the hygiene audit online.
For veterinary nurses, Schedule 3 is arguably one of the most important aspects of the Veterinary Surgeons Act, partly defining what it means to be a nurse, and defining what tasks veterinary surgeons can reasonably delegate.
Thus far, however, Schedule 3 has only been loosely defined, allowing for veterinary nurses to (under the direction of their veterinary surgeon employer) 'give medical treatment or carry out acts of minor surgery, not involving entry into a body cavity'.
There is evidence from the RCVS/BVNA VN Futures project that uncertainty about what this definition actually means in practice has stopped veterinary surgeons from delegating tasks which could both improve practice efficiency and make the role of the veterinary nurse more interesting, varied and rewarding.
The consultation - and the broader review of Schedule 3 of which it forms a part - aims to create a 'clarified and bolstered VN role via a reformed Schedule 3'.
Liz Cox, Chair of both the Schedule 3 Working Party and VN Council, said: "The future of veterinary nursing is both challenging and exciting, with the convergence of such factors as Brexit, the development of new technologies, and the increasing specialisation of veterinary surgeons, and we would very much like to know how you think the role of veterinary nurse will evolve.
"In light of this we very much encourage all veterinary nurses and veterinary surgeons to complete this consultation. Evidence gathered during the initial stage of the VN Futures project suggested that there is some uncertainty around the interpretation of Schedule 3 in clinical practice. For example, many veterinary nurses do not undertake Schedule 3 work or are uncertain as to whether they do, while some veterinary surgeons are reluctant to delegate Schedule 3 tasks to veterinary nurses.
"With this survey we hope to get a better steer on how Schedule 3 is used and interpreted in practice on a day-to-day basis and gather views on where both veterinary surgeons and veterinary nurses feel the current legislation could be clarified. Furthermore, we also want to know if there are areas of practice that are currently prohibited to nurses under current Schedule 3 arrangements that the professions believe could be opened up to veterinary nurses as a means of bolstering the profession."
Liz Cox and David Catlow MRCVS, Chair of the Standards Committee, will also be presenting a webinar on Thursday 11 May from 1pm to 2pm titled ‘The Art of Delegation – Schedule 3 Consultation’. It will focus on Schedule 3 and the role of the veterinary nurse, and explore possible areas to consider when responding to the consultation. To subscribe to the webinar, please visit The Webinar Vet’s website: www.thewebinarvet.com/webinar/art-delegation-schedule-3-consultation/
All eligible veterinary nurses and veterinary surgeons have been emailed with a link to survey.
Further information about the VN Futures project can be found at www.vetfutures.org.uk/vnfutures
Louise is an RCVS and EBVS European Specialist in Veterinary Anaesthesia and Analgesia, and a Past President of the Pain Medicine Section Council at the Royal Society of Medicine. She has also been an invited examiner on the European Diploma examination and a Treasurer of the Association of Veterinary Anaesthetists. She has headed the anaesthesia team at Davies since 2007.
Her tips are: